Global Stem Cell Umbilical Cord Blood (UCB) Market 2015-2019

Published: Aug 2015 Pages: 79 SKU: IRTNTR6649

About Stem Cell UCB

UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic and genetic disorders. The placental blood can produce 10 times more quantity of stem cells compared to the umbilical cord, which can, in turn, be used for the treatment of an adult patient. The cord blood that is collected during the childbirth is stored and cryopreserved. The storage of the cord blood can be done at private cord blood banks or public cord blood banks. This preserved blood can be used for the transplantation and treatment of diseases at the later stages of life and this factor increases stem cell UCB market value. According to the stem cell umbilical cord blood (UCB) market growth analysis, Technavio's analysts forecast the global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global stem cell UCB market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the banking and utilization of UCB stem cells for the treatment of various disorders, such as cancers, blood disorders, metabolic disorders, immune diseases, and others.

Technavio's report, Global Stem Cell UCB Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global stem cell UCB market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Caladrius Biosciences 
• Celgene 
• Mesoblast 
• Pluristem Therapeutics

Other Prominent Vendors
• Athersys
• CHA Bio & Diostech 
• Cytori Therapeutics
• Nuo Therapeutics 
• Ocata Therapeutics 
• Opexa Therapeutics 
• Osiris Therapeutics 
• Teva Pharmaceuticals 
• United Therapeutics 

Key Market Driver
• Effective Treatment of Life-threatening Diseases
• For a full, detailed list, view our report

Key Market Challenge
• Stringent Regulations
• For a full, detailed list, view our report

Key Market Trend
• Growing Public Awareness
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Technavio also provides customized reports based on the specific requirements of our clients.

 

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Process of Collection, Processing and Storage of Cord Blood Cells
06.1 Donor Evaluation
06.2 Collection Methods
06.3 Processing and Storage Methods
06.4 Sample Retention and Length of Storage
07. Facts: Cord Blood Units
08. US FDA Approved Stem Cell UCB Product
08.1 Hemacord
08.1.1 Mechanism of Action
08.1.2 Side Effects
09. Pipeline Analysis
09.1 Information on the Pipeline Candidates
09.1.1 PDA-002
09.1.2 PDA-001
09.1.3 PLX-PAD
09.1.4 PLX-R18
10. Market Landscape
10.1 Market Overview
10.2 Market Size and Forecast
10.3 Five Forces Analysis
11. Market Segmentation by Application
11.1 Cancers
11.2 Blood Disorders
11.3 Metabolic Disorders
11.4 Immune Disorders
11.5 Others
12. Market Segmentation by Storage
12.1 Public Cord Blood Bank
12.2 Private Cord Blood Bank
12.3 Public-Private Cord Blood Banks
13. Harmonization of Biobanking
14. Market Segmentation by End-users
14.1 Research Institutes
14.2 Pharmaceutical Companies
14.3 Biobanks
14.4 Hospitals
15. Geographical Segmentation
15.1 Stem Cell UCB Market in Americas
15.1.1 Market Size and Forecast
15.2 Stem Cell UCB Market in EMEA
15.2.1 Market Size and Forecast
15.3 Stem Cell UCB Market in APAC
15.3.1 Market Size and Forecast
16. Buying Criteria
17. Market Growth Drivers
18. Drivers and their Impact
19. Market Challenges
20. Impact of Drivers and Challenges
21. Market Trends
22. Trends and their Impact
23. Vendor Landscape
23.1 Competitive Scenario
23.1.1 Key News
23.1.2 Mergers and Acquisitions
23.2 Market Share Analysis 2014
23.2.1 Caladrius Biosciences
23.2.2 Celgene
23.2.3 Mesoblast
23.2.4 Pluristem Therapeutics
23.3 Other and Future Prominent Vendors
24. Global Stem Cell UCB Market: Key Takeaways
25. Key Vendor Analysis
25.1 Caladrious
25.1.1 Key Facts
25.1.2 Business Overview
25.1.3 Business Segmentation by Revenue 2014
25.1.4 Business Segmentation by Revenue 2013 and 2014
25.1.5 Geographical Segmentation by Revenue 2014
25.1.6 Business Strategy
25.1.7 Recent Developments
25.1.8 SWOT Analysis
25.2 Celgene
25.2.1 Key Facts
25.2.2 Business Overview
25.2.3 Business Strategy
25.2.4 Business Segmentation by Revenue
25.2.5 Sales by Geography
25.2.6 Key Information
25.2.7 SWOT Analysis
25.3 Mesoblast
25.3.1 Key Facts
25.3.2 Business Overview
25.3.3 Therapeutic Areas
25.3.4 Geographical Segmentation
25.3.5 Business Strategy
25.3.6 Recent Developments
25.3.7 SWOT Analysis
25.4 Pluristem
25.4.1 Key Facts
25.4.2 Business Overview
25.4.3 Geographical Presence
25.4.4 Business Strategy
25.4.5 Recent Developments
25.4.6 SWOT Analysis
26. Other Reports in this Series

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis